Firms

1540 Ventures

1540 Ventures is an early-stage investment firm with listed offices in New York and Fremont, California. It invests from pre-seed through Series A in medical devices and technology, life science tools, in-vitro diagnostics and women's health. Its stated areas of interest include TechBio at the intersection of digital biology and medicine, intelligent devices and data integration, software as a medical device, women's digital health, and digital manufacturing software and services. The firm works with corporate strategic investors, development partners and incubators, and seeks portfolio companies with identified milestones and interest from potential corporate or financial partners. Its official website identifies Rob King as Partner and Chief Investment Officer. In September 2025, AiM Medical Robotics named 1540 Ventures as co-lead of its $8.1 million Series A alongside IQ Capital, supporting MRI-compatible neurosurgical robotics for brain disorders and cancer. The firm does not disclose a complete portfolio directory or fund size on its current public website.

Founded: —
Type: Venture capital